Research Paper Volume 16, Issue 1 pp 872—910

XRCC1: a potential prognostic and immunological biomarker in LGG based on systematic pan-cancer analysis

class="figure-viewer-img"

Figure 10. The relationship between XRCC1 expression and pan-cancer molecular subtypes. (A) in BRCA, (B) in GBM, (C) in HNSC, (D) in KIRP, (E) in LGG, (F) in LIHC, (G) in OV, (H) in PCPG, (I) in PRAD, (J) in READ, (K) in STAD, (L) in UCEC.